SK bioscience Co.,Ltd. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	291,573	127,026	225,287	98,028
Short-Term Investments	162,989	275,300	5,300	-0
Trading Asset Securities	761,028	871,816	1,250,218	1,547,635
Cash & Short-Term Investments	1,215,590	1,274,141	1,480,806	1,645,663
Cash Growth	-0.42%	-13.96%	-10.02%	-
Accounts Receivable	10,443	12,928	39,585	38,006
Other Receivables	20,123	9,414	50,076	10,129
Receivables	30,566	22,342	89,661	48,135
Inventory	129,223	80,649	187,406	135,046
Prepaid Expenses	2,100	1,613	1,649	1,407
Other Current Assets	1,734	4,224	24,173	7,554
Total Current Assets	1,379,213	1,382,969	1,783,694	1,837,804
Property, Plant & Equipment	386,002	315,923	293,057	220,983
Long-Term Investments	101,141	42,729	1,500	21,610
Other Intangible Assets	13,962	14,178	6,299	3,973
Long-Term Deferred Tax Assets	54,432	59,219	21,370	10,242
Long-Term Deferred Charges	7,662	8,281	11,882	13,088
Other Long-Term Assets	23,994	29,140	24,129	2,422
Total Assets	1,966,407	1,852,439	2,141,931	2,110,123
Accounts Payable	11,386	3,370	11,053	63,812
Accrued Expenses	10,076	19,716	30,242	26,322
Short-Term Debt	-	-	45,550	11,671
Current Portion of Long-Term Debt	-	-	38,008	47,978
Current Portion of Leases	7,712	8,137	12,235	2,309
Current Income Taxes Payable	-	-	20,216	101,486
Other Current Liabilities	107,055	104,397	222,733	206,374
Total Current Liabilities	136,229	135,620	380,037	459,952
Long-Term Debt	80,000	-	-	35,503
Long-Term Leases	11,769	12,436	17,543	8,775
Other Long-Term Liabilities	618.82	527.84	2,649	335.24
Total Liabilities	228,617	148,584	400,229	508,811
Common Stock	38,414	38,414	38,392	38,250
Additional Paid-In Capital	1,160,456	1,160,456	1,160,008	1,157,064
Retained Earnings	524,294	549,421	533,378	405,305
Comprehensive Income & Other	14,627	-44,435	9,924	692.92
Shareholders' Equity	1,737,790	1,703,855	1,741,702	1,601,312
Total Liabilities & Equity	1,966,407	1,852,439	2,141,931	2,110,123
Total Debt	99,481	20,574	113,336	106,236
Net Cash (Debt)	1,116,109	1,253,568	1,367,469	1,539,428
Net Cash Growth	-6.55%	-8.33%	-11.17%	-
Net Cash Per Share	14488.23	16277.20	17754.39	20850.38
Filing Date Shares Outstanding	76.83	76.83	76.78	76.5
Total Common Shares Outstanding	76.83	76.83	76.78	76.5
Working Capital	1,242,985	1,247,350	1,403,657	1,377,852
Book Value Per Share	22619.30	22177.60	22683.12	20932.18
Tangible Book Value	1,723,828	1,689,678	1,735,403	1,597,339
Tangible Book Value Per Share	22437.57	21993.06	22601.09	20880.24
Land	45,280	45,280	45,270	9,949
Buildings	122,598	124,315	127,741	119,990
Machinery	54,816	55,879	53,141	51,037
Construction In Progress	139,809	65,638	33,153	25,884

Source: S&P Capital IQ. Standard template. Financial Sources.